Morningstar

Front Month Nymex ULSD Rose 0.61% to Settle at $4.5678 — Data Talk

Provided by Dow Jones

Front Month Nymex ULSD for Oct. delivery gained 2.76 cents per gallon, or 0.61% to $4.5678 today 




       --Largest one day dollar and percentage gain since Tuesday, Sept. 1, 2026 



       --Snaps a two session losing streak 



       --Up seven of the past nine sessions 



       --Today's settlement value is the fifth highest this year 



       --Off 2.44% from its 52-week high of $4.6822 hit Wednesday, Sept. 2, 2026 



       --Up 122.09% from its 52-week low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Rose 96.90% from 52 weeks ago 



       --Off 2.44% from its 2026 settlement high of $4.6822 hit Wednesday, Sept. 2, 2026 



       --Up 122.09% from its 2026 settlement low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Off 11.05% from its record high of $5.1354 hit Thursday, April 28, 2022 



       --Month-to-date it is up 1.65% 



       --Year-to-date it is up $2.4472 or 115.40% 





     All prices are calculated based on the settlement price of the current front month contract. 





     Source: Dow Jones Market Data 





  (END) Dow Jones Newswires



  September 08, 2026 15:00 ET (19:00 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
 
Plus, a deep dive on SpaceX’s bid to challenge US telecoms. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
Why This Vanguard ETF Is One of the Best
 
Vanguard Total International Stock is appealing for several reasons. 
 
 
Zachary Evens 
 
 
 
6 ETFs To Diversify Away From AI
 
A difficult problem has an easy solution. 
 
 
Daniel Sotiroff 
 
 
 
The Best AI Stocks to Buy Now
 
Artificial intelligence stocks continue to attract investors, thanks to industry momentum and appealing valuations. 
 
 
Tori Brovet 
 
 
 
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
 
Despite a looming patent cliff, a strong drug pipeline and 4.1% yield give investors reasons for optimism. 
 
 
Karen Andersen, CFA 
 
 
 
 

			Sponsor Center